Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 371

Results: 6
    1
    2
    3

    Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 371, p. 1, doi. 10.1126/scitranslmed.aaf5294
    By:
    • Wong, Pancras C.;
    • Seiffert, Dietmar;
    • Bird, J. Eileen;
    • Watson, Carol A.;
    • Bostwick, Jeffrey S.;
    • Giancarli, Mary;
    • Allegretto, Nick;
    • Ji Hua;
    • Harden, David;
    • Guay, Jocelyne;
    • Callejo, Mario;
    • Miller, Michael M.;
    • Lawrence, R. Michael;
    • Banville, Jacques;
    • Guy, Julia;
    • Maxwell, Brad D.;
    • Priestley, E. Scott;
    • Marinier, Anne;
    • Wexler, Ruth R.;
    • Bouvier, Michel
    Publication type:
    Article
    4
    5

    Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 371, p. 1, doi. 10.1126/scitranslmed.aad9099
    By:
    • Kublin, James G.;
    • Mikolajczak, Sebastian A.;
    • Sack, Brandon K.;
    • Fishbaugher, Matt E.;
    • Seilie, Annette;
    • Shelton, Lisa;
    • VonGoedert, Tracie;
    • Firat, Melike;
    • Magee, Sara;
    • Fritzen, Emma;
    • Betz, Will;
    • Kain, Heather S.;
    • Dankwa, Dorender A.;
    • Steel, Ryan W. J.;
    • Vaughan, Ashley M.;
    • Sather, D. Noah;
    • Murphy, Sean C.;
    • Kappe, Stefan H. I.
    Publication type:
    Article
    6